1. Home
  2. SQNS vs KYNB Comparison

SQNS vs KYNB Comparison

Compare SQNS & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

N/A

Current Price

$2.49

Market Cap

38.0M

Sector

Technology

ML Signal

N/A

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$3.73

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SQNS
KYNB
Founded
2003
1993
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0M
32.8M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
SQNS
KYNB
Price
$2.49
$3.73
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$9.33
★ $38.50
AVG Volume (30 Days)
★ 65.2K
23.3K
Earning Date
11-03-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9552.08
EPS
★ N/A
N/A
Revenue
N/A
★ $6,440,000.00
Revenue This Year
$24.60
N/A
Revenue Next Year
$68.32
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.31
$3.50
52 Week High
$6.98
$9.66

Technical Indicators

Market Signals
Indicator
SQNS
KYNB
Relative Strength Index (RSI) 44.64 27.82
Support Level $2.37 N/A
Resistance Level $3.15 $7.41
Average True Range (ATR) 0.16 0.39
MACD 0.01 -0.02
Stochastic Oscillator 17.74 15.72

Price Performance

Historical Comparison
SQNS
KYNB

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: